JBM (Healthcare) Limited
Research JBM (Healthcare) Limited (2161.HK) on Bullrun: market cap HKD 1.31B, P/E 6.4, dividend yield 11.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker2161.HK
- ExchangeHK
- CountryHong Kong
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyHKD
- Market capHKD 1.31B
- P/E6.4
- Dividend yield11.3%
- Financial periodFY2026
- RevenueHKD 834.63M
- Revenue growth6.7%
- Net incomeHKD 201.09M
- Free cash flowHKD 129.10M
- Gross margin55.8%
Valuation Snapshot
latest market cap is HKD 1.31B; P/E is 6.4; dividend yield is 11.3%.
Peer valuation comparison
Latest P/E is 6.4x versus a Healthcare sector median of 21.69x (70.5% below).
Latest dividend yield is 11.29% versus a Healthcare sector median of 2.41% (368.5% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | HKD 834.63M | HKD 201.09M | HKD 129.10M | 55.8% | n/a | HKD 119.94M | HKD 393.72M | HKD 1.08B |
| FY2025 | HKD 782.29M | HKD 197.26M | HKD 205.92M | 52.9% | 0.24 | HKD 205.85M | HKD 171.75M | HKD 1.08B |
| FY2024 | HKD 648.42M | HKD 130.46M | HKD 181.00M | 52.1% | 0.15 | HKD 140.81M | HKD 133.41M | HKD 970.68M |
| FY2023 | HKD 520.32M | HKD 57.09M | HKD 137.48M | 39.5% | 0.06 | HKD 152.27M | HKD 180.10M | HKD 985.51M |
| FY2022 | n/a | n/a | n/a | n/a | 0.03 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 1.31B | 6.4 | 9.2% | 0.15 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.15 HKD, yield 11.3%.
| Year | Dividends/share |
|---|---|
| FY2026 | 0.07 HKD |
| FY2025 | 0.21 HKD |
| FY2024 | 0.1 HKD |
| FY2023 | 0.06 HKD |
| FY2022 | 0.01 HKD |
About JBM (Healthcare) Limited
JBM (Healthcare) Limited, an investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, Singapore, and internationally. It operates through Branded Medicines, Proprietary Chinese Medicines, and Health and Wellness Products segments. The Branded Medicines segment develops, manufactures, and distributes branded medicines with chemical compounds as active ingredients.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is JBM (Healthcare) Limited's market cap?
JBM (Healthcare) Limited's market capitalization is HKD 1.31B.
What is JBM (Healthcare) Limited's P/E ratio?
JBM (Healthcare) Limited's price-to-earnings (P/E) ratio is 6.4.
Does JBM (Healthcare) Limited pay a dividend?
JBM (Healthcare) Limited has a dividend yield of 11.3%.
What does JBM (Healthcare) Limited do?
JBM (Healthcare) Limited, an investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, Singapore, and internationally. It operates through Branded Medicines, Proprietary Chinese Medicines, and Health and Wellness Products segments. The Branded Medicines segment develops, manufactures, and distributes branded medicines with chemical compounds as active ingredients.